Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
Baudax Bio Revenue
Baudax Bio had revenue of $1.27M in the twelve months ending September 30, 2023, up 217.25% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27M with 17.50% growth.
Revenue
1.27M
Revenue Growth
+217.25%
P/S Ratio
0.00
Revenue / Employee
141.00K
Employees
9
Market Cap
52.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1.27M | 189.00K | 17.50% |
| Dec 31, 2021 | 1.08M | 587.00K | 119.07% |
| Dec 31, 2020 | 493.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Chrome Holding Co. | 174.90M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 2.61M |